|
| 33288886 | NOP10 predicts lung cancer prognosis and its associated small nucleolar RNAs drive proliferation and migration. | Oncogene | 2021 |
| 30956778 | Specific allelic variants of SNPs in the and genes are associated with earlier tumor onset and progression in Caucasian breast cancer patients. | Oncotarget | 2019 |
| 27956623 | Mutant p53 promotes tumor progression and metastasis by the endoplasmic reticulum UDPase ENTPD5. | Proc Natl Acad Sci U S A | 2016 |
| 25728675 | TRIM25 has a dual function in the p53/Mdm2 circuit. | Oncogene | 2015 |
| 24654968 | Germline genetics of the p53 pathway affect longevity in a gender specific manner. | Current Aging Science | 2014 |
| 25530805 | Clinical utility of chromosomal microarray analysis in the diagnosis and management of monosomy 7 mosaicism. | Molecular Cytogenetics | 2014 |
| 24026681 | A mutation in a ganglioside biosynthetic enzyme, ST3GAL5, results in salt & pepper syndrome, a neurocutaneous disorder with altered glycolipid and glycoprotein glycosylation. | Human Molecular Genetics | 2014 |
| 23587880 | Disruption of MBD5 contributes to a spectrum of psychopathology and neurodevelopmental abnormalities. | Mol Psychiatry | 2014 |
| 23208842 | Clinical utility of the X-chromosome array. | American Journal of Medical Genetics, Part A | 2013 |
| 22833079 | Inverse expression of cystein-rich 61 (Cyr61/CCN1) and connective tissue growth factor (CTGF/CCN2) in borderline tumors and carcinomas of the ovary. | International Journal of Gynecological Pathology | 2012 |
| 22700878 | Alternate splicing of the p53 inhibitor HDMX offers a superior prognostic biomarker than p53 mutation in human cancer. | Cancer Research | 2012 |
| 21744492 | X-linked mental retardation with alacrima and achalasia-Triple A syndrome or a new syndrome? | American Journal of Medical Genetics, Part A | 2011 |
| 21271659 | 47, XY, +der(Y),t(X;Y)(p21.1;p11.2): a unique case of XY sex reversal. | American Journal of Medical Genetics, Part A | 2011 |
| 21485001 | Somatic/gonadal mosaicism in a syndromic form of ectrodactyly, including eye abnormalities, documented through array-based comparative genomic hybridization. | American Journal of Medical Genetics, Part A | 2011 |
| 21484992 | Deletion of the immunoglobulin domain of IL1RAPL1 results in nonsyndromic X-linked intellectual disability associated with behavioral problems and mild dysmorphism. | American Journal of Medical Genetics, Part A | 2011 |
| 21629300 | 17p13.3 microduplications are associated with split-hand/foot malformation and long-bone deficiency (SHFLD). | Eur J Hum Genet | 2011 |
| 20659896 | HDMX-L is expressed from a functional p53-responsive promoter in the first intron of the HDMX gene and participates in an autoregulatory feedback loop to control p53 activity. | Journal of Biological Chemistry | 2010 |
| 21084273 | An illegitimate microRNA target site within the 3' UTR of MDM4 affects ovarian cancer progression and chemosensitivity. | Cancer Research | 2010 |
| 19578782 | Small polydispersed circular DNA contains strains of mobile genetic elements and occurs more frequently in permanent cell lines of malignant tumors than in normal lymphocytes. | Oncology Reports | 2009 |
| 18172257 | Both germ line and somatic genetics of the p53 pathway affect ovarian cancer incidence and survival. | Clinical Cancer Research | 2008 |
| 18922973 | Association of HDM2 transcript levels with age of onset and prognosis in soft tissue sarcomas. | Molecular Cancer Research | 2008 |
| 18314620 | [Both somatic and germline genetics of the TP53-pathway influence ovarian cancer incidence and survival]. | Verhandlungen der Deutschen Gesellschaft fur Pathologie | 2007 |
| 17885676 | The effects of knockdown of wild-type survivin, survivin-2B or survivin-delta3 on the radiosensitization in a soft tissue sarcoma cells in vitro under different oxygen conditions. | Cancer Gene Therapy | 2007 |
| 17339335 | Thymomegaly, microsplenia, and defective homeostatic proliferation of peripheral lymphocytes in p51-Ets1 isoform-specific null mice. | Molecular and Cellular Biology | 2007 |
| 17525744 | Stem cell-associated genes are extremely poor prognostic factors for soft-tissue sarcoma patients. | Oncogene | 2007 |
| 16953229 | Expression of the stem cell self-renewal gene Hiwi and risk of tumour-related death in patients with soft-tissue sarcoma. | Oncogene | 2007 |
| 16707433 | MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent manner. | Cancer Res | 2006 |
| 15583820 | Radiosensitization, after a combined treatment of survivin siRNA and irradiation, is correlated with the activation of caspases 3 and 7 in a wt-p53 sarcoma cell line, but not in a mt-p53 sarcoma cell line. | Oncology Reports | 2005 |
| 15551306 | Alterations of cancer-related genes in soft tissue sarcomas: hypermethylation of RASSF1A is frequently detected in leiomyosarcoma and associated with poor prognosis in sarcoma. | International Journal of Cancer | 2005 |
| 16142348 | Detection of circulating tumor cells from renal carcinoma patients: experiences of a two-center study. | Oncology Reports | 2005 |
| 15540119 | Gains of 13q are correlated with a poor prognosis in liposarcoma. | Modern Pathology | 2005 |
| 15856009 | Elevated expression of survivin-splice variants predicts a poor outcome for soft-tissue sarcomas patients. | Oncogene | 2005 |
| 15906355 | Significance of HDMX-S (or MDM4) mRNA splice variant overexpression and HDMX gene amplification on primary soft tissue sarcoma prognosis. | International Journal of Cancer | 2005 |
| 14739938 | Knockdown of survivin expression by small interfering RNA reduces the clonogenic survival of human sarcoma cell lines independently of p53. | Cancer Gene Therapy | 2004 |
| 27137922 | [Not Available]. | Strahlenther Onkol | 2004 |
| 15550242 | A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. | Cell | 2004 |
| 15375518 | Radiosensitization of a human soft tissue sarcoma cell line US8-93 (mt-p53) with the oxidizer sodium peroxodisulfate. | Oncology Reports | 2004 |
| 15736417 | Analysis of central regulatory pathways in p53-deficient primary cultures of malignant fibrous histiocytoma exposed to ifosfamide. | Anticancer Research | 2004 |
| 16892553 | [HDMX amplification and high levels of HDMX-S splice variant are correlated with a poor prognosis in soft tissue sarcomas]. | Verhandlungen der Deutschen Gesellschaft fur Pathologie | 2004 |
| 14654951 | Expression of alternatively and aberrantly spliced transcripts of the MDM2 mRNA is not tumor-specific. | International Journal of Oncology | 2004 |
| 14757843 | MDM2 and its splice variant messenger RNAs: expression in tumors and down-regulation using antisense oligonucleotides. | Molecular Cancer Research | 2004 |
| 14751168 | Detection of disseminated tumor cells in peripheral blood of patients with breast cancer: correlation to nodal status and occurrence of metastases. | Gynecologic Oncology | 2004 |
| 12712483 | Reduced expression of hMSH2 protein is correlated to poor survival for soft tissue sarcoma patients. | Cancer | 2003 |
| 12894574 | Marker-assisted study of genetic background and gene-targeted locus modifiers in lymphopoietic phenotypes. | Anticancer Research | 2003 |
| 14614050 | Loss of heterozygosity at 12q14-15 often occurs in stage I soft tissue sarcomas and is associated with MDM2 amplification in tumors at various stages. | Modern Pathology | 2003 |
| 12631613 | Elevated expression level of survivin protein in soft-tissue sarcomas is a strong independent predictor of survival. | Clinical Cancer Research | 2003 |
| 11918915 | Co-expression of survivin and TERT and risk of tumour-related death in patients with soft-tissue sarcoma. | Lancet, The | 2002 |
| 12168836 | High bad and bcl-xL gene expression and combined bad, bcl-xL, bax and bcl-2 mRNA levels: molecular predictors for survival of stage 2 soft tissue sarcoma patients. | Anticancer Research | 2002 |
| 12168095 | Isolation and enrichment of urologic tumor cells in blood samples by a semi-automated CD45 depletion autoMACS protocol. | International Journal of Oncology | 2002 |
| 12389647 | Expression of cathepsin B, D and L protein in juvenile idiopathic arthritis. | Autoimmunity | 2002 |